Loading clinical trials...
Loading clinical trials...
An Open-label, Fixed Sequence Study in Healthy Participants to Assess the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole
Conditions
Interventions
AZD2389
Itraconazole
Locations
1
United States
Research Site
Brooklyn, Maryland, United States
Start Date
February 26, 2025
Primary Completion Date
April 23, 2025
Completion Date
April 23, 2025
Last Updated
April 29, 2025
NCT06342713
NCT07310901
NCT07471204
NCT07401472
NCT07412353
NCT07280858
Lead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions